Comparison Overview

A2&Co

VS

Pharmacy Times

A2&Co

None
Last Update: 2025-11-21
Between 750 and 799

Somos una familia obsesionada con el branding, no hacemos publicidad. Nos definimos como un equipo que explora con curiosidad el mundo para ofrecer a nuestros clientes soluciones creativas a los retos comunicacionales que imponen unos mercados altamente competitivos y dinámicos. La familia de A2&Co se crece con las sinergias que hemos hecho con La Comba Comunicaciones, Continental Solutions Inc e Imasen; para responder con rapidez y efectividad a los requerimientos que nuestros clientes nos presenten.

NAICS: 511
NAICS Definition: Publishing Industries (except Internet)
Employees: None
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0

Pharmacy Times

2 Commerce Dr, Cranbury, New Jersey, 08512, US
Last Update: 2025-11-26
Between 700 and 749

Pharmacy Times is a clinically-based, monthly journal providing practical information pharmacists can use in their everyday practice. Each issue contains articles and features covering medication errors, drug interactions, patient education, pharmacy technology, disease state management, patient counseling, product news, pharmacy law, and specialty pharmacy. Pharmacy Times Continuing Education (PTCE) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.

NAICS: 511
NAICS Definition: Publishing Industries (except Internet)
Employees: 1,855
Subsidiaries: 55
12-month incidents
0
Known data breaches
1
Attack type number
2

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/a2&co.jpeg
A2&Co
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
https://images.rankiteo.com/companyimages/pharmacy-times.jpeg
Pharmacy Times
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
Compliance Summary
A2&Co
100%
Compliance Rate
0/4 Standards Verified
Pharmacy Times
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Book and Periodical Publishing Industry Average (This Year)

No incidents recorded for A2&Co in 2025.

Incidents vs Book and Periodical Publishing Industry Average (This Year)

No incidents recorded for Pharmacy Times in 2025.

Incident History — A2&Co (X = Date, Y = Severity)

A2&Co cyber incidents detection timeline including parent company and subsidiaries

Incident History — Pharmacy Times (X = Date, Y = Severity)

Pharmacy Times cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/a2&co.jpeg
A2&Co
Incidents

No Incident

https://images.rankiteo.com/companyimages/pharmacy-times.jpeg
Pharmacy Times
Incidents

Date Detected: 08/2022
Type:Cyber Attack
Blog: Blog

Date Detected: 5/2018
Type:Breach
Attack Vector: Unauthorized Access
Blog: Blog

FAQ

A2&Co company demonstrates a stronger AI Cybersecurity Score compared to Pharmacy Times company, reflecting its advanced cybersecurity posture governance and monitoring frameworks.

Pharmacy Times company has historically faced a number of disclosed cyber incidents, whereas A2&Co company has not reported any.

In the current year, Pharmacy Times company and A2&Co company have not reported any cyber incidents.

Neither Pharmacy Times company nor A2&Co company has reported experiencing a ransomware attack publicly.

Pharmacy Times company has disclosed at least one data breach, while A2&Co company has not reported such incidents publicly.

Pharmacy Times company has reported targeted cyberattacks, while A2&Co company has not reported such incidents publicly.

Neither A2&Co company nor Pharmacy Times company has reported experiencing or disclosing vulnerabilities publicly.

Neither A2&Co nor Pharmacy Times holds any compliance certifications.

Neither company holds any compliance certifications.

Pharmacy Times company has more subsidiaries worldwide compared to A2&Co company.

Neither A2&Co nor Pharmacy Times holds SOC 2 Type 1 certification.

Neither A2&Co nor Pharmacy Times holds SOC 2 Type 2 certification.

Neither A2&Co nor Pharmacy Times holds ISO 27001 certification.

Neither A2&Co nor Pharmacy Times holds PCI DSS certification.

Neither A2&Co nor Pharmacy Times holds HIPAA certification.

Neither A2&Co nor Pharmacy Times holds GDPR certification.

Latest Global CVEs (Not Company-Specific)

Description

ThingsBoard in versions prior to v4.2.1 allows an authenticated user to upload malicious SVG images via the "Image Gallery", leading to a Stored Cross-Site Scripting (XSS) vulnerability. The exploit can be triggered when any user accesses the public API endpoint of the malicious SVG images, or if the malicious images are embedded in an `iframe` element, during a widget creation, deployed to any page of the platform (e.g., dashboards), and accessed during normal operations. The vulnerability resides in the `ImageController`, which fails to restrict the execution of JavaScript code when an image is loaded by the user's browser. This vulnerability can lead to the execution of malicious code in the context of other users' sessions, potentially compromising their accounts and allowing unauthorized actions.

Risk Information
cvss4
Base: 6.2
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:P/VC:N/VI:N/VA:N/SC:H/SI:L/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

Mattermost versions 11.0.x <= 11.0.2, 10.12.x <= 10.12.1, 10.11.x <= 10.11.4, 10.5.x <= 10.5.12 fail to to verify that the token used during the code exchange originates from the same authentication flow, which allows an authenticated user to perform account takeover via a specially crafted email address used when switching authentication methods and sending a request to the /users/login/sso/code-exchange endpoint. The vulnerability requires ExperimentalEnableAuthenticationTransfer to be enabled (default: enabled) and RequireEmailVerification to be disabled (default: disabled).

Risk Information
cvss3
Base: 9.9
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:H
Description

Mattermost versions 11.0.x <= 11.0.2, 10.12.x <= 10.12.1, 10.11.x <= 10.11.4, 10.5.x <= 10.5.12 fail to sanitize team email addresses to be visible only to Team Admins, which allows any authenticated user to view team email addresses via the GET /api/v4/channels/{channel_id}/common_teams endpoint

Risk Information
cvss3
Base: 4.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N
Description

Exposure of email service credentials to users without administrative rights in Devolutions Server.This issue affects Devolutions Server: before 2025.2.21, before 2025.3.9.

Description

Exposure of credentials in unintended requests in Devolutions Server.This issue affects Server: through 2025.2.20, through 2025.3.8.